News Center

August 20, 2025

Introducing a Curated Cardiomyopathies and Arrhythmia Panel with Unparalleled Specificity, Sensitivity and Clinical Utility

Hereditary cardiomyopathies and arrhythmias are major contributors to morbidity and mortality worldwide. Cardiomyopathy refers to primary disorders of the cardiac...
March 18, 2025

Improving Clinical Diagnostics of Repeat Expansion Disorders with Combined Short and Long-Read WGS

See how our use of combined short and long-read WGS is improving diagnostic performance of testing for neurological disorders caused by repeat expansions.
October 15, 2024

Variantyx Combines Long and Short Reads for Rare Disease Whole-Genome Diagnostic Test

GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford...
September 18, 2024

Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0

FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
May 21, 2024

Longer ZFHX3 repeat lengths correlate with earlier age of onset of SCA4

For years scientists believed they knew where the causal gene for spinocerebellar ataxia (SCA4) could be found, but the identity...
April 26, 2024

Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase

FRAMINGHAM, Mass. April 26, 2024 (Business Wire) – Variantyx, a leader in molecular diagnostics, announced today that it has secured...
November 30, 2023

Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders

FRAMINGHAM, Mass. November 30, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced that the set of...
November 10, 2023

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
October 18, 2023

Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint

FRAMINGHAM, Mass. October 18, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine today, announced that it has secured...
July 28, 2023

PGx testing informs clinical management for cancer patients

Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...